Distribution
Bringing innovative MedTech to market & into clinical practice.
Our distribution work sits at the intersection of commercial insight and clinical impact. From AI-powered imaging software to specialist devices for breast health and diagnostics, we partner with emerging and established MedTech innovators to bring high-quality products to healthcare providers across the UK, Europe and beyond.
With a strong foundation in regulatory understanding and commercial strategy, we support market entry and product adoption through well-aligned, scalable distribution models — tailored to the needs of hospitals, private clinics, and diagnostic providers.
If you're exploring distribution opportunities in the UK, Europe or other international markets, contact us to discuss how we can support your launch.
nu:view
AB-CT Advanced Breast CT
We are the UK distribution partner for AB-CT’s nu:view, the world’s first breast CT scanner to use spiral CT technology with photon-counting detectors.
Designed to provide high-resolution, 3D imaging with low radiation dose and without breast compression, nu:view offers a patient-friendly alternative to traditional mammography — with applications in early detection, diagnostics, and treatment planning. Our role includes supporting clinical evaluation, market education, and adoption across NHS and private healthcare settings.
If you're interested in learning more about nu:view or would like to discuss procurement, please get in touch.
SwiftMR
AIRS Medical
MediLife was the original UK distributor for SwiftMR by AIRS Medical — an AI-powered solution that enhances MRI efficiency by accelerating scan times and improving image quality through deep learning reconstruction.
The success of SwiftMR’s early market adoption led to the creation of Med AI Solutions, a dedicated business established to support the growing demand for advanced imaging technologies. Today, Med AI Solutions manages distribution across the UK and Germany, providing technical implementation, clinical support, and strategic guidance to imaging providers adopting SwiftMR.
If you're interested in bringing SwiftMR to your organisation, please contact Med AI Solutions to discuss your requirements.
ClariCT.AI
ClariPi
MediLife initially led the UK introduction of ClariCT.AI by ClariPi — an FDA-cleared and CE-certified deep learning solution that significantly reduces noise in low-dose CT scans without compromising image quality.
As clinical interest and adoption grew, ClariCT.AI became part of the Med AI Solutions portfolio, ensuring dedicated distribution and support across the UK. Today, Med AI Solutions provides end-to-end implementation, technical integration, and clinical education for providers looking to enhance CT image quality and reduce patient radiation exposure.
If you're interested in bringing ClariCT.AI to your organisation, please contact Med AI Solutions to discuss your requirements.
NeoNavia
NeoDynamics
MediLife supported the UK introduction of NeoNavia, a pulse biopsy system developed by NeoDynamics to enhance precision and control in breast tissue sampling.
Designed for use in both diagnostic and therapeutic procedures, NeoNavia combined patented pulse technology with a modular needle system to improve targeting accuracy in challenging lesions. Our involvement focused on clinical engagement, market development, and supporting early adoption within NHS and private breast care centres.
